The company plans to submit a Biologics Licence Application to the US Food and Drug Administration later in 2025 for its DMD ...

The FDA has removed the clinical hold on vTv Therapeutics' cadisegliatin clinical programme, including the Phase III CATT1 trial for T1D.

Orca Bio’s T-cell immunotherapy candidate for blood cancers has more than doubled the number of patients surviving free of ...

Zealand Pharma has concluded enrolment for its global, randomised Phase IIb ZUPREME-1 trial, assessing petrelintide.

The United States is experiencing a multi-state measles outbreak, resulting in the highest case spike since 2019.

The two simultaneous Incyte trials in HS saw more than 40% of patients on povorcitinib achieving a clinical response.

Anocca has secured authorisation from regulatory authorities in four European nations for its Phase I/II VIDAR-1 clinical ...

The Phase I/II trial sought to establish the impact of DYNE-251 on mobility-related endpoints, seeing an increase over ...

AbbVie has reported analysis from a Phase III trial that assessed Elahere against chemotherapy for platinum-resistant ovarian ...

On this World Tuberculosis Day, a renewed commitment must be made to reach all patients with TB and prevent the spread of disease. Credit: Andrew Angelov via Shutterstock. The international community ...

Results saw all 24 healthy volunteers who made it to the 72-week mark still had effective levels of dMAb in their systems.

Endometriosis is a chronic condition in which tissue similar to the uterine lining grows outside the uterus. Credit: crystal light via Shutterstock. The National Health Service (NHS) in England has ...